Having a leading expert in each indication to represent LL to the experts in research and in BP seems to be where we have been headed since CA took over. If Dr. Recknor is gone, it would indicate we are no longer in need of someone who does the nuts and bolts of a trial. If he is still there, it would indicate one of two things to me, one is keeping track of nuts and bolts of future partnerships and two would be to hammer Amarex.